Monash IVF Group (ASX:MVF) - Aktienkurs, Nachrichten und Analyse

MVF Aktienübersicht

Die Monash IVF Group Limited bietet Dienstleistungen im Bereich der assistierten Reproduktion und der Bildgebung für Frauen in Australien und Malaysia an.

Über das Unternehmen

MVF fundamental analysis
Snowflake Score
Valuation	5/6
Future Growth	2/6
Past Performance	5/6
Financial Health	4/6
Dividends	3/6

Belohnungen

65.4% unter unserer Schätzung des beizulegenden Zeitwerts gehandelt

Prognostiziertes Gewinnwachstum 13.06% pro Jahr

Die Erträge stiegen im vergangenen Jahr um 41.3%

Im Vergleich zu Wettbewerbern und der Branche gut bewertet

Risikoanalyse

Unbeständige Dividendenentwicklung

Monash IVF Group Limited Wettbewerber

Pacific Smiles Group

ASX:PSQ

AU$300.8m

Ramsay Health Care

ASX:RHC

AU$11.0b

Australian Clinical Labs

ASX:ACL

AU$493.2m

Paragon Care

ASX:PGC

AU$687.0m

Preisentwicklung & Leistung

Summary of all time highs, changes and price drops for Monash IVF Group
Historical stock prices
Current Share Price	AU$1.34
52 Week High	AU$1.53
52 Week Low	AU$1.11
Beta	1.49
1 Month Change	-8.84%
3 Month Change	-7.59%
1 Year Change	16.52%
3 Year Change	57.65%
5 Year Change	-6.29%
Change since IPO	-29.66%

Aktuelle Nachrichten und Updates

Monash IVF Group's (ASX:MVF) Dividend Will Be A$0.025

Feb 26

Recent updates

Shareholders Will Probably Not Have Any Issues With Monash IVF Group Limited's (ASX:MVF) CEO Compensation

Nov 04

Monash IVF Group's (ASX:MVF) Upcoming Dividend Will Be Larger Than Last Year's

Aug 29

Be Wary Of Monash IVF Group (ASX:MVF) And Its Returns On Capital

May 14

Should You Think About Buying Monash IVF Group Limited (ASX:MVF) Now?

Jun 06

Monash IVF Group (ASX:MVF) May Have Issues Allocating Its Capital

May 25

Is Monash IVF Group Limited (ASX:MVF) Expensive For A Reason? A Look At Its Intrinsic Value

May 13

Is Monash IVF Group Limited (ASX:MVF) A Smart Choice For Dividend Investors?

Mar 14

Just Four Days Till Monash IVF Group Limited (ASX:MVF) Will Be Trading Ex-Dividend

Mar 04

Monash IVF Group Limited (ASX:MVF) Just Released Its Half-Year Results And Analysts Are Updating Their Estimates

Feb 26

Is Now An Opportune Moment To Examine Monash IVF Group Limited (ASX:MVF)?

Feb 15

A Look At The Fair Value Of Monash IVF Group Limited (ASX:MVF)

Feb 03

We're Not So Sure You Should Rely on Monash IVF Group's (ASX:MVF) Statutory Earnings

Jan 22

Is Monash IVF Group Limited (ASX:MVF) Popular Amongst Institutions?

Jan 10

Is Monash IVF Group (ASX:MVF) Using Too Much Debt?

Dec 28

What Do The Returns On Capital At Monash IVF Group (ASX:MVF) Tell Us?

Dec 17

Monash IVF Group's (ASX:MVF) Shareholders Are Down 56% On Their Shares

Dec 06

Monash IVF Group Limited's (ASX:MVF) On An Uptrend But Financial Prospects Look Pretty Weak: Is The Stock Overpriced?

Nov 24

Aktionärsrenditen

	MVF	AU Healthcare	AU Markt
7D	0.4%	0.3%	-1.7%
1Y	16.5%	-21.7%	7.0%

Rendite im Vergleich zur Industrie: MVF übertraf die Branche Australian Healthcare, die im vergangenen Jahr eine Rendite von -20.9 erzielte.

Rendite vs. Markt: MVF übertraf den Markt Australian, der im vergangenen Jahr eine Rendite von 8.8 erzielte.

Preisvolatilität

Is MVF's price volatile compared to industry and market?
MVF volatility
MVF Average Weekly Movement	3.2%
Healthcare Industry Average Movement	5.3%
Market Average Movement	8.7%
10% most volatile stocks in AU Market	16.3%
10% least volatile stocks in AU Market	3.2%

Stabiler Aktienkurs: MVF hatte in den letzten 3 Monaten keine nennenswerte Preisvolatilität.

Volatilität im Zeitverlauf: MVFDie wöchentliche Volatilität (3%) ist im vergangenen Jahr stabil geblieben.

Über das Unternehmen

Gegründet	Mitarbeiter	CEO	Website
2014	867	Michael Knaap	www.monashivfgroup.com.au

Die Monash IVF Group Limited bietet Dienstleistungen im Bereich der assistierten Reproduktion und der Bildgebung für Frauen in Australien und Malaysia an. Das Unternehmen bietet diagnostische geburtshilfliche und gynäkologische Ultraschalluntersuchungen sowie Fruchtbarkeitsbehandlungen an. Es bietet auch pränatale Diagnostik und IVF-Behandlung auf Tertiärniveau an.

Monash IVF Group Limited's Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von Monash IVF Group im Vergleich zum Marktanteil des Unternehmens?
MVF grundlegende Statistiken
Marktanteil	AU$522.11m
Gewinn(TTM)	AU$23.97m
Umsatz(TTM)	AU$235.97m

21.8x

Kurs-Gewinn-Verhältnis

2.2x

Kurs-Umsatz-Verhältnis

Ist MVF zu teuer?

Siehe Fair Value und Bewertungsanalyse

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
MVF Gewinn- und Verlustrechnung (TTM)
Einnahmen	AU$235.97m
Kosten der Einnahmen	AU$155.53m
Bruttogewinn	AU$80.45m
Sonstige Ausgaben	AU$56.48m
Umsatz	AU$23.97m

Zuletzt gemeldete Gewinne

Dec 31, 2023

Datum des nächsten Gewinnberichts

Aug 22, 2024

Gewinn per Aktie (EPS)	0.062
Bruttomarge	34.09%
Nettogewinnspanne	10.16%
Schulden/Eigenkapital-Verhältnis	15.2%

Wie hat sich MVF auf lange Sicht entwickelt?

Historische Performance und Vergleiche

Dividenden

3.4%

Aktuelle Dividendenrendite

73%

Ausschüttungsquote

MVF Aktienübersicht

Belohnungen

Risikoanalyse

Monash IVF Group Limited Wettbewerber

ASX:PSQ

AU$300.8m

ASX:RHC

AU$11.0b

ASX:ACL

AU$493.2m

ASX:PGC

AU$687.0m

Preisentwicklung & Leistung

Aktuelle Nachrichten und Updates

Monash IVF Group Limited (ASX:MVF)completed the acquisition of 80% stake in Fertility North Holdings Pty Ltd.

Upcoming dividend of AU$0.025 per share

Monash IVF Group Limited Appoints Cathy Aston as an Independent Non-Executive Director and A Member of the Audit and Risk Management Committee Effective from 26 February 2024

Monash IVF Group Limited Appoints Cathy Aston as an Independent Non-Executive Director and A Member of the Audit and Risk Management Committee Effective from 26 February 2024

First half 2024 earnings released: EPS: AU$0.033 (vs AU$0.027 in 1H 2023)

Monash IVF Group's (ASX:MVF) Dividend Will Be A$0.025

Recent updates

Monash IVF Group Limited (ASX:MVF)completed the acquisition of 80% stake in Fertility North Holdings Pty Ltd.

Upcoming dividend of AU$0.025 per share

Monash IVF Group Limited Appoints Cathy Aston as an Independent Non-Executive Director and A Member of the Audit and Risk Management Committee Effective from 26 February 2024

Monash IVF Group Limited Appoints Cathy Aston as an Independent Non-Executive Director and A Member of the Audit and Risk Management Committee Effective from 26 February 2024

First half 2024 earnings released: EPS: AU$0.033 (vs AU$0.027 in 1H 2023)

Monash IVF Group's (ASX:MVF) Dividend Will Be A$0.025

First half dividend of AU$0.025 announced

Monash IVF Group Limited to Report First Half, 2024 Results on Feb 23, 2024

Price target increased by 7.3% to AU$1.42

Upcoming dividend of AU$0.022 per share at 3.5% yield

Monash IVF Group (ASX:MVF) Will Pay A Dividend Of A$0.022

Monash IVF Group Limited Announces Fully Franked Final Dividend for Fiscal Year Ended June 30, 2023, Payable on 11 October 2023

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Monash IVF Group Limited Provides Update on Class Action Lawsuit

Monash IVF Group Limited (ASX:MVF) completed the acquisition of PIVET Medical Centre.

Upcoming dividend of AU$0.022 per share at 4.2% yield

First half 2023 earnings released: EPS: AU$0.027 (vs AU$0.031 in 1H 2022)

Monash IVF Group Limited to Report First Half, 2023 Results on Feb 21, 2023

Here's What's Concerning About Monash IVF Group's (ASX:MVF) Returns On Capital

Insufficient new directors

Shareholders Will Probably Not Have Any Issues With Monash IVF Group Limited's (ASX:MVF) CEO Compensation

Monash IVF Group Limited (ASX:MVF) completed the acquisition of ART Associates Queensland #2 Pty Ltd.

Consensus forecasts updated

Upcoming dividend of AU$0.022 per share

Monash IVF Group's (ASX:MVF) Upcoming Dividend Will Be Larger Than Last Year's

Full year 2022 earnings: EPS misses analyst expectations

Monash IVF Group Limited Announces Ordinary Fully Paid Distribution for the Six Months Ended June 30, 2022, Payable on October 7, 2022

Monash IVF Group Limited to Report Fiscal Year 2022 Results on Aug 26, 2022

Monash IVF Group Limited, Annual General Meeting, Nov 11, 2022

Insufficient new directors

Monash IVF Group Limited (ASX:MVF) agreed to acquire PIVET Medical Centre for AUD 9.4 million.

Consensus EPS estimates fall by 16%

Be Wary Of Monash IVF Group (ASX:MVF) And Its Returns On Capital

Consensus EPS estimates fall by 10%

Insufficient new directors

Monash IVF Group Limited Announces Fully Franked Distribution for the Six Months That Ended December 31, 2021, Payable on April 4, 2022

Monash IVF Group Limited to Report First Half, 2022 Results on Feb 17, 2022

Monash IVF Group Limited Updates Temporary Suspension of IVF Procedures Lifted in Victoria

Upcoming dividend of AU$0.021 per share

Full year 2021 earnings released: EPS AU$0.065 (vs AU$0.046 in FY 2020)

Price target increased to AU$1.08

Should You Think About Buying Monash IVF Group Limited (ASX:MVF) Now?

Monash IVF Group (ASX:MVF) May Have Issues Allocating Its Capital

Is Monash IVF Group Limited (ASX:MVF) Expensive For A Reason? A Look At Its Intrinsic Value

Independent Non-Executive Director recently bought AU$192k worth of stock

Is Monash IVF Group Limited (ASX:MVF) A Smart Choice For Dividend Investors?

Just Four Days Till Monash IVF Group Limited (ASX:MVF) Will Be Trading Ex-Dividend

Monash IVF Group Limited (ASX:MVF) Just Released Its Half-Year Results And Analysts Are Updating Their Estimates

Revenue and earnings beat expectations

First half 2021 earnings released: EPS AU$0.037 (vs AU$0.035 in 1H 2020)

New 90-day high: AU$0.80

Is Now An Opportune Moment To Examine Monash IVF Group Limited (ASX:MVF)?

A Look At The Fair Value Of Monash IVF Group Limited (ASX:MVF)

We're Not So Sure You Should Rely on Monash IVF Group's (ASX:MVF) Statutory Earnings

Is Monash IVF Group Limited (ASX:MVF) Popular Amongst Institutions?

Is Monash IVF Group (ASX:MVF) Using Too Much Debt?

What Do The Returns On Capital At Monash IVF Group (ASX:MVF) Tell Us?

Monash IVF Group's (ASX:MVF) Shareholders Are Down 56% On Their Shares

Price target raised to AU$0.88

Erträge & Einnahmen